Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
high-throughput screening method
|
| gptkbp:advantage |
reduces false positives
enables more accurate hit identification generates quantitative data for each compound |
| gptkbp:appliesTo |
cell-based assays
biochemical assays |
| gptkbp:contrastsWith |
traditional high-throughput screening
|
| gptkbp:developedBy |
National Institutes of Health Chemical Genomics Center
|
| gptkbp:enables |
dose-response curve generation
efficacy determination potency determination |
| gptkbp:firstDescribed |
2006
|
| https://www.w3.org/2000/01/rdf-schema#label |
qHTS
|
| gptkbp:relatedTo |
gptkb:HTS
dose-response analysis |
| gptkbp:standsFor |
quantitative high-throughput screening
|
| gptkbp:usedIn |
chemical biology
drug discovery |
| gptkbp:uses |
multiple concentrations per compound
|
| gptkbp:bfsParent |
gptkb:LINCS
|
| gptkbp:bfsLayer |
7
|